Paradigm Health Secures $78M Series B to Embed Clinical Trials in Global Routine Healthcare
Paradigm Health has raised $78 million in an oversubscribed Series B round as the U.S. technology company accelerates its effort to embed clinical trials directly within routine patient care across the country and abroad. The investment was led by ARCH Venture Partners, joined by new backer DFJ Growth and returning investors including F-Prime, General Catalyst,…